25C-NBF

From Wikipedia, the free encyclopedia

Other names2C-C-NBF; NBF-2C-C; N-(2-Fluorobenzyl)-4-chloro-2,5-dimethoxyphenethylamine
ATC code
  • None
Legal status
25C-NBF
Clinical data
Other names2C-C-NBF; NBF-2C-C; N-(2-Fluorobenzyl)-4-chloro-2,5-dimethoxyphenethylamine
Drug classSerotonin receptor agonist; Serotonin 5-HT2A receptor agonist
ATC code
  • None
Legal status
Legal status
Identifiers
  • 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethanamine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC17H19ClFNO2
Molar mass323.79 g·mol−1
3D model (JSmol)
  • COC1=CC(=C(C=C1CCNCC2=CC=CC=C2F)OC)Cl
  • InChI=1S/C17H19ClFNO2/c1-21-16-10-14(18)17(22-2)9-12(16)7-8-20-11-13-5-3-4-6-15(13)19/h3-6,9-10,20H,7-8,11H2,1-2H3
  • Key:AHIUIEOLKNDLSC-UHFFFAOYSA-N

25C-NBF (2C-C-NBF, NBF-2C-C) is a derivative of the phenethylamine hallucinogen 2C-C, which acts as a highly potent partial agonist for the human 5-HT2A receptor.[2][3][4] It produces psychoplastogenic and rapid antidepressant-like effects in preclinical research.[4]

Sweden

The Riksdag added 25C-NBF to Narcotic Drugs Punishments Act under swedish schedule I ("substances, plant materials and fungi which normally do not have medical use") as of January 26, 2016, published by Medical Products Agency (MPA) in regulation HSLF-FS 2015:35 listed as 25C-NBF, and 2-(4-kloro-2,5-dimetoxifenyl)-N-(2-fluorobensyl)etanamin.[5]

United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[6]

See also

References

Related Articles

Wikiwand AI